Osteo Advantage TM
Natural health product licensed in Canada
- Other names
- Arti Joint Rx TM
- Licence holder
- Konsar Future Nutrition Inc.
- NPN or DIN-HM
- 80051825
- Status
- Inactive licence
- Licence date
- 16 June 2014
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine D: up to 25 µg a day according to the dosing instructions published by Health Canada (1 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 5 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Acide hyaluronique Source : Streptococcus equi - capsule extracellulaire bactérienne | 200 mg | Not calculated |
| Extrait de boswellia serrata Source : Boswellia sacra - résine (écorce de tige) Potency : 30 % Boswellic acid | 250 mg | Not calculated |
| Collagen de type II non dénaturé Source : Gallus gallus - cartilage | 40 mg | Not calculated |
| Vitamin K2 Source : Ménaquinone 7 | 45 mcg | 45 µg |
| Vitamine D Source : Cholécalciférol | 25 mcg | 25 µg |
| Vitamine D Source : Cholécalciférol | 1,000 UI | 25 µg |
| Harpagophytum procumbens Source : Racine(s) secondaire(s) tubérisée(s) Extraction ratio : 30:1 Dry plant equivalent : 3 g | 100 mg | Not calculated |
Non-medicinal ingredients
Hypromellose, Dicalcium phosphate, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps in the maintenance of bones. Helps support joint health. Helps to relieve joint pain associated with osteoarthritis of the knee. Helps in the absorption and use of calcium and phosphorus.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80051825
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.